Nothing wrong with making GLP-1s freely available to all who want them if it improves metabolic health, reduces addiction, reduces cancer and inflammation risk,

Nothing wrong with making GLP-1s freely available to all who want them if it improves metabolic health, reduces addiction, reduces cancer and inflammation risk, etc. Side effects are known and data to date shows risks are low. Ship it to everyone who wants it imho and kick off the longitudinal study. The aggregate potential benefit is so high and the risk and cost reasonably low. Certainly, no one should ever be forced to take it, or be experimented on without their explicit, informed consent (and "experimented on" in this context is "taking the GLP-1 already and we're just tracking the outcomes at scale").